ARS Pharmaceuticals Inc.

NASDAQ: SPRY · Real-Time Price · USD
14.53
0.06 (0.41%)
At close: Aug 15, 2025, 3:59 PM
14.65
0.83%
After-hours: Aug 15, 2025, 07:32 PM EDT

ARS Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
8M -54.37M -34.68M -20.24M
Depreciation & Amortization
-7.17M 73K 319K 6K
Stock-Based Compensation
14.53M 9.23M 5.84M 2.83M
Other Working Capital
-4.12M -4.55M -2.47M -6.39M
Other Non-Cash Items
n/a -6.88M 1.2M 207K
Deferred Income Tax
n/a n/a n/a -4K
Change in Working Capital
-1.81M -7.33M -12.75M -356K
Operating Cash Flow
13.55M -59.27M -40.08M -17.56M
Capital Expenditures
-563K -175K -199K -55K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-356.04M -272M n/a -65.11M
Sales Maturities Of Investments
258M 185M n/a n/a
Other Investing Acitivies
-7.5M n/a n/a 65.11M
Investing Cash Flow
-106.1M -87.18M -199K -55K
Debt Repayment
69.38M n/a -8.68M -1.82M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 198.84M 169K
Financial Cash Flow
72.4M 6.9M 190.73M 53.16M
Net Cash Flow
-20.15M -139.55M 150.46M 35.54M
Free Cash Flow
12.98M -59.44M -40.28M -17.62M